• Home
• Our products
• Vaccines

Vaccines

We market over 25 vaccines worldwide to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis.

The majority of our vaccine R&D activities are conducted at GlaxoSmithKline Biologicals in Rixensart, Belgium. Over 1300 of our research scientists are devoted to developing new vaccines and more cost-effective and convenient combination vaccines to prevent infections that cause serious medical problems worldwide.

We are also targeting therapeutic vaccines that may prevent relapse in cancer patients. The strength of our vaccine pipeline will provide opportunities for us to consistently deliver new vaccines for many years to come.

Within this section of our website, you find the Patient Information Leaflets or Prescribing Information for our vaccines. Please note that this information is often specific to a country or region and is not intended to replace the advice of a qualified doctor.

• View a list of vaccines available in the UK
• View a list of vaccines available in the US

Products are in various stages of approval around the world and may not be available in every country.

The vaccines listed under the US trademarks link are for United States residents only. Vaccines listed under the UK trademarks link are for United Kingdom residents only.

Back to top